Physicochemical and toxicological profiling of ash from the 2010 and 2011 eruptions of Eyjafjallajökull and Grímsvötn volcanoes, Iceland using a rapid respiratory hazard assessment protocol.

The six week eruption of Eyjafjallajökull volcano in 2010 produced heavy ash fall in a sparsely populated area of southern and south eastern Iceland and disrupted European commercial flights for at least 6 days. We adopted a protocol for the rapid analysis of volcanic ash particles, for the purpose of informing respiratory health risk assessments. Ash collected from deposits underwent a multi-laboratory physicochemical and toxicological investigation of their mineralogical parameters associated with bio-reactivity, and selected in vitro toxicology assays related to pulmonary inflammatory responses. Ash from the eruption of Grímsvötn, Iceland, in 2011 was also studied. The results were benchmarked against ash from Soufrière Hills volcano, Montserrat, which has been extensively studied since the onset of eruptive activity in 1995. For Eyjafjallajökull, the grain size distributions were variable: 2-13 vol% of the bulk samples were <4 µm, with the most explosive phases of the eruption generating abundant respirable particulate matter. In contrast, the Grímsvötn ash was almost uniformly coarse (<3.5 vol%<4 µm material). Surface area ranged from 0.3 to 7.7 m2 g(-1) for Eyjafjallajökull but was very low for Grímsvötn (<0.6 m2 g(-1)). There were few fibre-like particles (which were unrelated to asbestos) and the crystalline silica content was negligible in both eruptions, whereas Soufrière Hills ash was cristobalite-rich with a known potential to cause silicosis. All samples displayed a low ability to deplete lung antioxidant defences, showed little haemolysis and low acute cytotoxicity in human alveolar type-1 like epithelial cells (TT1). However, cell-free tests showed substantial hydroxyl radical generation in the presence of hydrogen peroxide for Grímsvötn samples, as expected for basaltic, Fe-rich ash. Cellular mediators MCP-1, IL-6, and IL-8 showed chronic pro-inflammatory responses in Eyjafjallajökull, Grímsvötn and Soufrière Hills samples, despite substantial differences in the sample mineralogy and eruptive styles. The value of the pro-inflammatory profiles in differentiating the potential respiratory health hazard of volcanic ashes remains uncertain in a protocol designed to inform public health risk assessment, and further research on their role in volcanic crises is warranted.

[1]  P. Baxter,et al.  Assessment of the exposure of islanders to ash from the Soufriere Hills volcano, Montserrat, British West Indies , 2002, Occupational and environmental medicine.

[2]  Sang Hee Lee,et al.  Montserrat volcanic ash induces lymph node granuloma and delayed lung inflammation. , 2004, Toxicology.

[3]  The May 2011 eruption of Grímsvötn , 2012 .

[4]  T. Sandström,et al.  Altered lung antioxidant status in patients with mild asthma , 1999, The Lancet.

[5]  E. Llewellin,et al.  The nature and formation of cristobalite at the Soufrière Hills volcano, Montserrat: implications for the petrology and stability of silicic lava domes , 2013, Bulletin of Volcanology.

[6]  Thorvaldur Thordarson,et al.  Ash generation and distribution from the April-May 2010 eruption of Eyjafjallajökull, Iceland , 2012, Scientific Reports.

[7]  Andre E Nel,et al.  Tracheobronchial particle dose considerations for in vitro toxicology studies. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  G. Cressey,et al.  Cristobalite in a rhyolitic lava dome: evolution of ash hazard , 2010 .

[9]  Helgi Björnsson,et al.  Eight centuries of periodic volcanism at the center of the Iceland hotspot revealed by glacier tephrostratigraphy , 1998 .

[10]  R. Harrison,et al.  Evaluating the Toxicity of Airborne Particulate Matter and Nanoparticles by Measuring Oxidative Stress Potential — A Workshop Report and Consensus Statement , 2008 .

[11]  C. Oppenheimer,et al.  Volcanic ash-leachates: a review and recommendations for sampling methods , 2005 .

[12]  A. Kane Mechanisms of mineral fibre carcinogenesis. , 1996, IARC scientific publications.

[13]  K. Donaldson,et al.  In vitro toxicology of respirable Montserrat volcanic ash , 2000, Occupational and environmental medicine.

[14]  L. Alleman,et al.  Development of an in vitro method to estimate lung bioaccessibility of metals from atmospheric particles. , 2011, Journal of environmental monitoring : JEM.

[15]  J. Lodge Air quality guidelines for Europe: WHO regional publications, European series, No. 23, World Health Organization, 1211 Geneva 27, Switzerland; WHO publications center USA, 49 Sheridan Avenue, Albany, NY 12210, 1987, xiii + 426 pp. price: Sw. fr. 60 , 1988 .

[16]  V. Vallyathan,et al.  Mount St. Helens' volcanic ash: hemolytic activity. , 1983, Environmental research.

[17]  Gordon Woo,et al.  Long term exposure to respirable volcanic ash on Montserrat: a time series simulation , 2006 .

[18]  B. Fubini,et al.  Sakurajima volcano: a physico-chemical study of the health consequences of long-term exposure to volcanic ash , 2012, Bulletin of Volcanology.

[19]  P. Baxter,et al.  Mineralogical analyses and in vitro screening tests for the rapid evaluation of the health hazard of volcanic ash at Rabaul volcano, Papua New Guinea , 2010 .

[20]  B. Forbes,et al.  Inflammatory Response and Barrier Properties of a New Alveolar Type 1-Like Cell Line (TT1) , 2009, Pharmaceutical Research.

[21]  W. MacNee,et al.  Aluminium lactate treatment of DQ12 quartz inhibits its ability to cause inflammation, chemokine expression, and nuclear factor-kappaB activation. , 2001, Toxicology and applied pharmacology.

[22]  Freysteinn Sigmundsson,et al.  Intrusion triggering of the 2010 Eyjafjallajökull explosive eruption , 2010, Nature.

[23]  F. Pooley,et al.  Pulmonary epithelial response in the rat lung to instilled Montserrat respirable dusts and their major mineral components , 2002, Occupational and environmental medicine.

[24]  J. Hardy,et al.  Iron in Asbestos Chemistry and Carcinogenicity , 1995 .

[25]  K. Donaldson,et al.  The structure of volcanic cristobalite in relation to its toxicity; relevance for the variable crystalline silica hazard , 2012, Particle and Fibre Toxicology.

[26]  T. Thordarson,et al.  Postglacial volcanism in Iceland , 2008, Jökull.

[27]  Y. Ikarashi,et al.  Haemolysis of various mammalian erythrocytes in sodium chloride, glucose and phosphate-buffer solutions , 1979, Laboratory animals.

[28]  Thorvaldur Thordarson,et al.  Distal deposition of tephra from the Eyjafjallajökull 2010 summit eruption , 2012 .

[29]  S. Loughlin,et al.  Chapter 21 Controls on variations in cristobalite abundance in ash generated by the Soufrière Hills Volcano, Montserrat in the period 1997 to 2010 , 2014 .

[30]  P. Demers,et al.  Radiographic evidence of silicosis risk in the diatomaceous earth industry. , 1998, American journal of respiratory and critical care medicine.

[31]  David M. Brown,et al.  The Importance of Surface Area and Specific Reactivity in the Acute Pulmonary Inflammatory Response to Particles , 2002 .

[32]  J. Paulauskis,et al.  Differential ability of transition metals to induce pulmonary inflammation. , 2001, Toxicology and applied pharmacology.

[33]  Deborah Jarvis,et al.  Volcanic ash and respiratory symptoms in children on the island of Montserrat, British West Indies , 2003, Occupational and environmental medicine.

[34]  Y. Korchev,et al.  Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. , 2008, American journal of respiratory cell and molecular biology.

[35]  Peter J. Baxter,et al.  The respiratory health hazard of tephra from the 2010 Centennial eruption of Merapi with implications for occupational mining of deposits , 2013 .

[36]  T. Gislason,et al.  A survey of early health effects of the Eyjafjallajökull 2010 eruption in Iceland: a population-based study , 2012, BMJ Open.

[37]  B. Plikaytis,et al.  Mount St. Helens eruptions: the acute respiratory effects of volcanic ash in a North American community. , 1983, Archives of environmental health.

[38]  Ivana Fenoglio,et al.  Surface reactivity of volcanic ash from the eruption of Soufrière Hills volcano, Montserrat, West Indies with implications for health hazards. , 2003, Environmental research.

[39]  B. Christenson Geochemistry of fluids associated with the 1995-1996 eruption of Mt. Ruapehu, New Zealand : signatures and processes in the magmatic-hydrothermal system , 2000 .

[40]  P. Baxter,et al.  The respiratory health hazards of volcanic ash: a review for volcanic risk mitigation , 2006 .

[41]  A. Stohl,et al.  High levels of particulate matter in Iceland due to direct ash emissions by the Eyjafjallajökull eruption and resuspension of deposited ash , 2012 .

[42]  R. Bernstein,et al.  Mount St Helens eruptions, May 18 to June 12, 1980. An overview of the acute health impact. , 1981, JAMA.

[43]  Murphy,et al.  Cristobalite in volcanic ash of the soufriere hills volcano, montserrat, british west indies , 1999, Science.

[44]  Ivana Fenoglio,et al.  Iron-induced hydroxyl radical generation from basaltic volcanic ash , 2007 .

[45]  M. Stevens,et al.  Assessment of cell line models of primary human cells by Raman spectral phenotyping. , 2010, Biophysical journal.

[46]  R. Sparks,et al.  Characterization of respirable volcanic ash from the Soufrière Hills volcano, Montserrat, with implications for human health hazards , 2003 .

[47]  T. Gislason,et al.  Health effects following the Eyjafjallajökull volcanic eruption: a cohort study , 2012, BMJ Open.

[48]  A. Buist,et al.  A four-year prospective study of the respiratory effects of volcanic ash from Mt. St. Helens. , 1986, The American review of respiratory disease.

[49]  C. Horwell Grain-size analysis of volcanic ash for the rapid assessment of respiratory health hazard. , 2007, Journal of environmental monitoring : JEM.

[50]  G. Cressey,et al.  A rapid method for quantifying single mineral phases in heterogeneous natural dusts using X-ray diffraction , 2009, Powder Diffraction.

[51]  B. Fubini,et al.  Free radical generation at the solid/liquid interface in iron containing minerals. , 1995, Free radical research.

[52]  K. Donaldson,et al.  Toxicity of volcanic ash from Montserrat , 2005 .

[53]  D. Morata,et al.  Formation of cristobalite nanofibers during explosive volcanic eruptions , 2009 .

[54]  A. Bertagnini,et al.  A physico-chemical assessment of the health hazard of Mt. Vesuvius volcanic ash. , 2010 .

[55]  P. Borm,et al.  Inflammatory effects of respirable quartz collected in workplaces versus standard DQ12 quartz: particle surface correlates. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[56]  V. Appanna,et al.  Zinc toxicity alters mitochondrial metabolism and leads to decreased ATP production in hepatocytes , 2008, Journal of applied toxicology : JAT.

[57]  R. G. Smith,et al.  Agronomic impact of tephra fallout from the 1995 and 1996 Ruapehu Volcano eruptions, New Zealand , 1998 .

[58]  C. Oppenheimer,et al.  Near-source observations of aerosol size distributions in the eruptive plumes from Eyjafjallajökull volcano, March–April 2010 , 2011 .

[59]  O. Morton,et al.  Chemical variations of tephra-fall deposit leachates for three eruptions from Popocatépetl volcano , 2002 .

[60]  Miguel A. Rico-Ramirez,et al.  EGU General Assembly , 2011 .

[61]  E. Yano,et al.  Chronic pulmonary effects of volcanic ash: an epidemiologic study. , 1986, Archives of environmental health.

[62]  Julia Gorelik,et al.  Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles , 2012, Nanotoxicology.

[63]  A. Kibble,et al.  Syndromic surveillance to assess the potential public health impact of the Icelandic volcanic ash plume across the United Kingdom, April 2010. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[64]  Peter J. Baxter,et al.  Chapter 22 Evaluating the respiratory health risks of volcanic ash at the eruption of the Soufrière Hills Volcano, Montserrat, 1995 to 2010 , 2014 .